Novartis
NVS
$96.30
Share price
0.39%
Change (1 day)
5.88%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
P/S ratio for Novartis (NVS)
P/S ratio as of December 2023 (TTM): 3.77
According to Novartis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.77376. At the end of 2023 the company had a P/S ratio of 4.03.
P/S ratio history for Novartis from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.03 | 6.94% |
| 2022 | 3.77 | 1.33% |
| 2021 | 3.72 | -14.86% |
| 2020 | 4.36 | -1.11% |
| 2019 | 4.41 | 15.06% |
| 2018 | 3.84 | -2.47% |
| 2017 | 3.93 | 12.4% |
| 2016 | 3.50 | -15.42% |
| 2015 | 4.14 | 1.29% |
| 2014 | 4.08 | 23.46% |
| 2013 | 3.31 | 25.02% |
| 2012 | 2.65 | 13.79% |
| 2011 | 2.33 | -10.9% |
| 2010 | 2.61 | -5.84% |
| 2009 | 2.77 | 4.1% |
| 2008 | 2.66 | -15.1% |
| 2007 | 3.14 | -15.14% |
| 2006 | 3.70 | -2.15% |
| 2005 | 3.78 | -13% |
| 2004 | 4.34 | -4.67% |
| 2003 | 4.55 | 16.84% |
| 2002 | 3.90 | -18.42% |
| 2001 | 4.78 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.10 | 8.55% | 🇺🇸 USA |
 Pfizer PFE | 2.36 | -37.50% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.52 | 19.79% | 🇺🇸 USA |
 Sanofi SNY | 2.42 | -35.80% | 🇫🇷 France |
 Merck MRK | 4.44 | 17.60% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.27 | -39.81% | 🇺🇸 USA |
 AstraZeneca AZN | 4.43 | 17.38% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2.05 | -45.72% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 0.7412 | -80.36% | 🇮🇱 Israel |